These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 27270326)
21. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
22. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. Huang WC; Tung SL; Chen YL; Chen PM; Chu PY BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739 [TBL] [Abstract][Full Text] [Related]
24. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor. Wang K; Liang Q; Wei L; Zhang W; Zhu P Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589 [TBL] [Abstract][Full Text] [Related]
27. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
29. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Heo MJ; Kim YM; Koo JH; Yang YM; An J; Lee SK; Lee SJ; Kim KM; Park JW; Kim SG Oncotarget; 2014 May; 5(9):2792-806. PubMed ID: 24798342 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation. Li Y; Xiao F; Li W; Hu P; Xu R; Li J; Li G; Zhu C Oncol Rep; 2019 Apr; 41(4):2075-2088. PubMed ID: 30816485 [TBL] [Abstract][Full Text] [Related]
31. microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma. Lu Z; Li X; Xu Y; Chen M; Chen W; Chen T; Tang Q; He Z Cell Death Dis; 2019 Sep; 10(10):723. PubMed ID: 31558704 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1. Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017 [TBL] [Abstract][Full Text] [Related]
33. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma. Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563 [TBL] [Abstract][Full Text] [Related]
35. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b. Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214 [TBL] [Abstract][Full Text] [Related]
37. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway. Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016 [TBL] [Abstract][Full Text] [Related]
39. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286 [TBL] [Abstract][Full Text] [Related]
40. PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells. Liu T; Zu CH; Wang SS; Song HL; Wang ZL; Xu XN; Liu HS; Wang YL; Shen ZY Oncotarget; 2016 Jul; 7(28):43376-43389. PubMed ID: 27270320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]